for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Bristol-Myers says EU advanced melanoma drug

May 11 (Reuters) - Bristol-myers Squibb Co

* European Commission Approves The First And Only Immuno-Oncology Combination, Bristol-Myers Squibb’s Opdivo (Nivolumab) + Yervoy (Ipilimumab) Regimen, For Treatment Of Advanced Melanoma

* Bristol Myers Squibb Co - Opdivo + Yervoy Regimen Now Approved For Unresectable Or Metastatic Melanoma Patients, Regardless Of Braf Mutational Status Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up